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Background: International literature suggests that disadvantaged groups are at higher risk of morbidity and
mortality from SARS-CoV-2 infection due to poorer living/working conditions and barriers to healthcare access.
Yet, to date, there is no evidence of this disproportionate impact on non-national individuals, including economic
migrants, short-term travellers and refugees. Methods: We analyzed data from the Italian surveillance system of
all COVID-19 laboratory-confirmed cases tested positive from the beginning of the outbreak (20th of February)
to the 19th of July 2020. We used multilevel negative-binomial regression models to compare the case fatality
and the rate of admission to hospital and intensive care unit (ICU) between Italian and non-Italian nationals. The
analysis was adjusted for differences in demographic characteristics, pre-existing comorbidities, and period of
diagnosis. Results: We analyzed 213 180 COVID-19 cases, including 15 974 (7.5%) non-Italian nationals. We found
that, compared to Italian cases, non-Italian cases were diagnosed at a later date and were more likely to be
hospitalized f[adjusted rate ratio (ARR)¼1.39, 95% confidence interval (CI): 1.33–1.44]g and admitted to ICU
(ARR¼1.19, 95% CI: 1.07–1.32), with differences being more pronounced in those coming from countries with
lower human development index (HDI). We also observed an increased risk of death in non-Italian cases from low-
HDI countries (ARR¼1.32, 95% CI: 1.01–1.75). Conclusions: A delayed diagnosis in non-Italian cases could explain
their worse outcomes compared to Italian cases. Ensuring early access to diagnosis and treatment to non-Italians
could facilitate the control of SARS-CoV-2 transmission and improve health outcomes in all people living in Italy,
regardless of nationality.
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Introduction
In December 2019, an outbreak of a novel coronavirus (SARS-CoV-2) emerged in China and spread rapidly worldwide, being
declared by the World Health Organization a public health emer-
gency of international concern on 30 January 2020 and a global
pandemic on 11 March 2020.1 Since then, as of the 23rd of
August, the pandemic has caused 800 000 deaths globally.2
In order to effectively control the pandemic and assess its impact,
it is essential to consider how it affects different population groups.
International reports suggest that minority ethnic groups are dis-
proportionally affected by SARS-CoV-2 infection due to cultural,
behavioural and societal characteristics, including disadvantaged
socioeconomic conditions, diverse health-seeking behaviour and
intergenerational cohabitation.3–7 Some of these aspects may also
apply to migrant populations as recent articles have called to con-
sider.8 Yet, to date, there is no evidence of this disproportionate
impact on this population group. There is evidence, however, that
international migrants are more likely to be socioeconomically
deprived, to suffer from job insecurity and to be marginalized, all
of which are risk factors associated with poor health and poor access
to healthcare.9 International migrants are also more likely to be
employed in low-skilled jobs that have been associated with an
increased risk of SARS-CoV-2 infection, such as care work, hospi-
tality or construction.10,11 There is evidence, as well, that migrants
face administrative, cultural and language barriers when accessing
healthcare.12,13
Italy has been one of the most severely affected countries during the
first wave of the pandemic. By mid-August 2020, over 250 000 persons
had been diagnosed with the infection, and over 35 000 had died from
it.14 In January 2020, almost 5.3 million foreign citizens were estimated
to be living in Italy (8.8% of the total resident population).15
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On one side, there is concern that non-Italian nationals may be
affected differently by the SARS-CoV-2 pandemic compared with
the local population, in particular, if the barriers described lead to
underdiagnosis or to a delayed diagnosis of SARS-CoV-2.
On the other side, however, considering the strong association
between COVID-19 related deaths and older age and comorbid-
ities,16,17 it is also possible that foreign persons may be at lower
risk of being severely affected by SARS-CoV-2 infection given that,
in spite of the higher risk of unhealthy lifestyles associated with
disadvantaged socioeconomic conditions, they are generally younger
and healthier compared with the local population.18 It is also con-
troversial whether Bacillus Calmette–Guérin (BCG) vaccine could
have a protective effect against SARS-CoV-2 infection, 19,20 with
possible benefit among foreigners from countries where BCG vac-
cination is routinely implemented.21
In this article, we describe the epidemiology of the SARS-CoV-2
infection among non-Italian cases tested positive in Italy, comparing
their distribution over time, case fatality, hospitalization rate and
rate of admission to intensive care unit (ICU) with those observed in
the Italian cases.
Methods
This study was conducted using routinely collected data and did not
rely on a pre-existing analysis plan. We described the methods and
presented findings according to the reporting guidelines for obser-
vational studies that are based on routinely collected health data (the
RECORD statement—checklist of items extended from the STROBE
statement) (Supplementary table S1).22
Data sources
We used information retrieved from the Italian national case-base
COVID-19 surveillance system established on 27 February 2020 and
coordinated by the Italian National Institute of Health.23 As previ-
ously described,16 the system collects data on all cases of SARS-CoV-
2 infection in Italy laboratory-confirmed by RT-PCR, following the
international case definition.24 The system collects information on
the demographic and clinical characteristics of COVID-19 cases,
including reported nationality and outcome of the infection (e.g.
hospitalization, admission to ICU and death). Data are collected
and entered daily by the 19 regions and the two autonomous prov-
inces using a secure online platform. Data are checked for out-of-
range values, inconsistencies and duplicated records at the coordi-
nating centre. A list of possible errors in data-entry is routinely sent
to regions for verification and possible corrections. For the purpose
of this study, we used the complete dataset of notifications updated
on 25 August 2020 and selected all COVID-19 cases tested positive
in Italy from the 20th of February to the 19th of July 2020, thus,
accounting for at least 30 days of follow-up since the date of testing
and a week of possible delay in information updating.
The scientific dissemination of COVID-19 surveillance data was
authorized by the Italian Presidency of the Council of Ministers on
27 February 2020 (Ordinance n. 640).
Outcomes, exposure and confounders
Among all notified COVID-19 cases, we defined as non-Italian
nationals all people with a reported non-Italian nationality, regard-
less of citizenship or country of birth. We classified the nationality as
Italian vs. non-Italian in general and according to the 2018 human
development index (HDI) of the country of origin.25 To this pur-
pose, we defined three categories based on the tertiles of the world’s
countries HDI distribution (low-HDI country: HDI0.651;
medium-HDI country: 0.651<HDI<0.799; and high-HDI country:
0.799).
We analyzed the associations between nationality (exposure) and
different outcomes. First, we assessed and compared the case fatality,
both overall and among hospitalized cases, considering COVID-19
associated deaths any notified person who was confirmed to be
infected with SARS-CoV-2 and has died within 30 days since the
date of testing positive. Second, within the same time-interval, we
assessed and compared the hospitalization rate and, among cases
who were hospitalized, the rate of admission to ICU.
We considered as potential confounders of the relationship be-
tween nationality and outcomes the following variables: sex, age
(categorized as <30 years of age, 5-years age groups from 30–
34 years to 60–74 years of age and 75 years of age), Italian geo-
graphical macro-area of diagnosis (i.e. North-West, North-East,
Centre, and South and Islands), level of urbanization of the place
of residence (i.e. urban, semi-urban and rural), pre-existing comor-
bidities (i.e. presence of at least one of oncologic, cardiovascular,
respiratory and diabetes/metabolic diseases) and calendar period of
testing (i.e. 30-day time intervals from 20 February–19 March to
20 June–19 July).
Statistical analysis
We excluded from the analysis, all cases presenting data inconsis-
tencies (i.e. death occurred before hospitalization), cases who
were imported from abroad, and those with missing information
about nationality. Moreover, we excluded from the multivariable
analysis all cases with missing information about age, level of
urbanization of the residence area and pre-existing comorbidities
(see figure 1).
We described the main demographic and clinical characteristics
and the distribution of cases over time by nationality using counts
with percentages and median with interquartile range (IQR) for
categorical and continuous variables, respectively.
We used multilevel negative-binomial regression models to
estimate the adjusted rate ratios (ARR) of death, hospitalization,
and admission to ICU for non-Italian cases compared to Italian
cases. Rate ratios (RRs) were adjusted for sex, age group, geograph-
ical macro-area of diagnosis, level of urbanization of the place of
residence, pre-existing comorbidities and calendar period of
diagnosis. A random effect accounting for regional differences in
health contexts and strategies was also included into the models.
All estimates were presented together with their 95% confidence
interval (CI).
We tested possible interactions between nationality and each
covariate included into the multivariable models through the
likelihood-ratio test.
Finally, to evaluate a possible selection bias due to missing infor-
mation about nationality, we conducted a sensitivity analysis assum-
ing that cases with no information about nationality but with a fiscal
code indicative that they were born abroad or in Italy were non-
Italian nationals or Italian nationals, respectively.
All tests were two-sided and statistical significance was set at
P<0.05. The analyses were performed using Stata/SE version 16.0
(StataCorp LLC, Texas, USA).
Results
After the exclusion of cases presenting data inconsistencies [15
(0.006%)], cases imported from abroad [789 (0.32%)], and those
with missing information about nationality [30 404 (12.4%)], a total
of 213 180 (87.2%) out of the 244 388 initial cases were included in
the analysis (see figure 1). Of these, 15 974 were non-Italian nation-
als (7.5%) and 197 206 were Italian nationals (92.5%). Among the
non-Italian nationals, almost all had an Italian fiscal code indicating
that they were regular migrants [15 546 (97.3%)].








niversity of Technology user on 22 June 2021
Socio-demographic characteristics and time of
diagnosis
According to the distribution by world’s macro-area presented in
Supplementary figure S1, cases of COVID-19 among non-Italian
nationals occurred in people from various countries. Non-Italian
cases from low-HDI countries were almost all from south-central
Africa [1834 (53.6%)] and Asia [1553 (45.4%)]. Non-Italian cases
from medium-HDI countries were mainly from south-central
America [3551 (42.0%)], European countries outside the
European Union (EU) [2606 (30.8%)] and North Africa [1517
(18.0%)], while non-Italians from high-HDI countries were in large
part from other EU countries [3447 (84.0%)].
Among all COVID-19 cases, compared with Italian nationals
[91 376 males (46.3%)], non-Italian nationals were less frequently
males [6871 (43.0%)], especially those from high-HDI countries
[1150 (28.0%)], while the difference was reversed in non-Italian
nationals from low-HDI countries [2372 (69.3%)] (table 1). All
cases among non-Italian nationals (median age: 44 years; IQR: 35–
53) were younger than Italian cases (median age: 63 years; IQR: 48–
80), especially those from low-HDI countries (median age: 37 years;
IQR: 28–46). Non-Italian nationals were more frequently diagnosed
in northern Italy and residing in urban areas [9662 (60.5%) and
8172 (52.0%), respectively] compared to Italian nationals [106 276
(53.9%) and 64 802 (33.1%), respectively]. This difference was more
evident among non-Italian nationals from medium-HDI countries
[5668 (67.1%) and 4764 (57.1%), respectively].
Pre-existing comorbidities were less frequently reported in non-
Italian cases [2597 (16.5%)] compared to Italian cases [78 283
(39.8%)], especially in those from low-HDI countries [433
(13.0%)].
In general, non-Italian cases were diagnosed on a later date com-
pared with Italian cases (see figure 2). The median date of testing
positive was 14 April (IQR: 28 March–8 May) for non-Italian
nationals compared to 1 April (IQR: 20 March–18 April) for
Italian nationals. This difference was particularly evident among
non-Italian nationals from low-HDI countries (median date at diag-
nosis: 29 April; IQR: 6 April–22 June).
Case fatality, hospitalization rate and rate of admis-
sion to ICU
Table 2 shows the crude and adjusted RRs of death, hospitalization
and admission to ICU in non-Italian nationals compared to Italian
nationals (RRs by all covariates included in the models are presented
in Supplementary tables S2, S3 and S5). Overall, we observed no
differences in case fatality between non-Italian nationals and Italian
nationals. The only exception was for non-Italian nationals from
low-HDI countries, who showed an increased risk of death com-
pared to Italian nationals (Adj. RR¼1.32, 95% CI: 1.01–1.75), al-
though this difference was not observed among hospitalized cases.
Moreover, we found that hospitalization rate was significantly
higher in cases among non-Italian nationals (Adj. RR¼1.39, 95%
Figure 1 Selection of COVID-19 cases included in the study. ICU, intensive care unit
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CI: 1.33–1.34), especially in those from low-HDI countries (Adj.
RR¼1.59, 95% CI: 1.48–1.71).
Finally, we found that the rate of admission to ICU among hos-
pitalized cases was also higher in non-Italian nationals compared to
Italian nationals (Adj. RR¼1.19, 95% CI: 1.07–1.32), particularly in
those from medium-HDI countries (Adj. RR¼1.25, 95% CI: 1.11–
1.42) and low-HDI countries (Adj. RR¼1.16, 95% CI: 0.93–1.44).
With reference to the risk of hospitalization, we found significant
interactions between nationality and sex (P¼0.001), age group
(P<0.001), geographical macro-area of diagnosis (P<0.001), pres-
ence of pre-existing comorbidities (P<0.001) and calendar period of
diagnosis (P<0.001). However, stratum-specific estimates of RR of
hospitalization for non-Italian cases compared to Italian cases were
generally in the same direction as in the main model (detailed results
from models with interaction terms are presented in Supplementary
table S4).
Discussion
The results show that, at this stage of the COVID-19 epidemic in
Italy, non-Italian cases were more likely to be hospitalized and to be
admitted to ICU compared with Italian cases, also showing a higher
probability to die from the infection in those from low-HDI coun-
tries. We observed an inverse gradient by which the risk of hospi-
talization, admission to ICU and death increased as the HDI of the
country of origin decreased.
The epidemic curves of non-Italian nationals appear shifted to the
right, indicating a median date of diagnosis 2 weeks later com-
pared with that of Italian nationals (4 weeks later among non-Italian
nationals from low-HDI countries). This suggests that non-Italian
cases were diagnosed in a less timely fashion than Italian cases,
possibly when the disease was more advanced and symptoms
more severe. A seroprevalence study of SARS-CoV-2 conducted in
North-eastern Italy corroborates this hypothesis, showing that im-
migrant women were more likely to be tested only when their symp-
toms were severe.26 Moreover, a delay of diagnosis in the foreign
population has been previously described for other infections in
Italy, such as tuberculosis.27 The delay in diagnosis, likely associated
with worse clinical conditions, could explain the increased rate of
hospitalization, admission to ICU, and death that we observed
among non-Italian nationals compared to Italian nationals, especial-
ly in those from low-HDI countries.
In Italy, all non-Italian nationals are granted to access emergency
services and some out-patient services,28 while access to additional
services, including being assigned to a general practitioner, the most
likely mediator for early diagnosis, occurs only when non-Italian
nationals live in Italy with a documented status. However, regardless
of status, informal barriers (language, administrative, legal, cultural
and social) hinder the prompt access to healthcare services, likely
leading to a delayed diagnosis.12,13 In the pandemic context, non-
Italian nationals also might have delayed diagnosis fearing restric-
tion of working activities due to isolation/quarantine.29 These














n (%) n (%) n (%) n (%) n (%)
Sex
Female 105 830 (53.7) 9103 (57.0) 1050 (30.7) 5100 (60.4) 2953 (72.0)
Male 91 376 (46.3) 6871 (43.0) 2372 (69.3) 3349 (39.6) 1150 (’28.0)
Age group
<30 years 15 794 (8.0) 2504 (15.7) 993 (29.0) 1140 (13.5) 371 (9.0)
30–34 years 6649 (3.4) 1430 (9.0) 497 (14.5) 664 (7.9) 269 (6.6)
35–39 years 7040 (3.6) 1865 (11.7) 496 (14.5) 920 (10.9) 449 (10.9)
40–44 years 9145 (4.6) 2339 (14.6) 457 (13.4) 1247 (14.8) 635 (15.5)
45–49 years 14 309 (7.3) 2246 (14.1) 383 (11.2) 1189 (14.1) 674 (16.4)
50–54 years 17 055 (8.6) 1989 (12.5) 229 (6.7) 1141 (13.5) 619 (15.1)
55–59 years 17 677 (9.0) 1434 (9.0) 157 (4.6) 887 (10.5) 390 (9.5)
60–64 years 14 499 (7.4) 894 (5.6) 101 (3.0) 539 (6.4) 254 (6.2)
65.69 years 12 501 (6.3) 506 (3.2) 53 (1.5) 327 (3.9) 126 (3.1)
70–74 years 14 307 (7.3) 261 (1.6) 23 (0.7) 171 (2.0) 67 (1.6)
75 years 68 225 (34.6) 506 (3.2) 33 (1.0) 224 (2.7) 249 (6.1)
Median age (IQR) 63 years (48–80) 44 years (35–53) 37 years (28–46) 45 years (36–55) 47 years (39–55)
Geographical macro-area
North-West 106 276 (53.9) 9662 (60.5) 1714 (50.1) 5668 (67.1) 2280 (55.6)
North-East 54 224 (27.5) 4737 (29.7) 1303 (38.1) 2086 (24.7) 1348 (32.9)
Centre 21 496 (10.9) 1198 (7.5) 328 (9.6) 554 (6.6) 316 (7.7)
South and Islands 15 210 (7.7) 377 (2.4) 77 (2.3) 141 (1.7) 159 (3.9)
Level of urbanization
Urban 64 802 (33.1) 8172 (52.0) 1843 (55.1) 4764 (57.1) 1565 (38.8)
Semi-urban 94 623 (48.3) 5950 (37.8) 1212 (36.2) 2863 (34.3) 1875 (46.5)
Rural 36 453 (18.6) 1606 (10.2) 290 (8.7) 721 (8.6) 595 (14.7)
Pre-existing comorbiditiesa
No 118 236 (60.2) 13 141 (83.5) 2893 (87.0) 6878 (82.5) 3370 (82.8)
Yes 78 283 (39.8) 2597 (16.5) 433 (13.0) 1464 (17.5) 700 (17.2)
Period of diagnosis
20 February–19 March 46 315 (23.5) 2033 (12.7) 297 (8.7) 1133 (13.4) 603 (14.7)
20 March–19 April 103 614 (52.5) 6902 (43.2) 1092 (31.9) 3910 (46.3) 1900 (46.3)
20 April–19 May 34 597 (17.5) 3993 (25.0) 788 (23.0) 2115 (25.0) 1090 (26.6)
20 May–19 June 9190 (4.7) 1324 (8.3) 315 (9.2) 730 (8.6) 279 (6.8)
20 June–19 July 3490 (1.8) 1722 (10.8) 930 (27.2) 561 (6.6) 231 (5.6)
IQR, interquartile range.
The number of cases might not add to the total because of missing information.
a: At least one of oncologic, cardiovascular, respiratory and diabetes/metabolic diseases.
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hypotheses could partly explain the less pronounced decline in in-
cidence observed after the start of the lockdown measures in non-
Italian nationals compared to Italian nationals. In fact, the circula-
tion of the virus in the foreign community could have been higher
because of non-Italian cases who were diagnosed late and were not
promptly isolated/quarantined at an earlier stage of the disease.
Differences in the epidemic curves could also be explained by a
different pace in the penetration of the disease in Italian and non-
Italian communities. It is possible that areas with low percentage of
non-Italian nationals were affected at an earlier stage, thus shifting
the curve of non-Italian cases to the right. However, in that case,
under the assumption that the median survival time after diagnosis
was the same in the two groups, we would expect a similar shift in
the distribution of deaths over time. Although we did observe a
delay in the median date of death of non-Italians compared with
Italians (4 days), considering that the median survival time of non-
Italian dead cases was 2 days higher than that of their Italian coun-
terpart, the magnitude of this delay was 85% smaller compared with
the delay in diagnosis (2 days vs. 13 days). This suggests that a dif-
ferent pace of penetration of the disease influenced the shift only
partially.
Finally, looking at the epidemic curve, we observed a new increase
in the number of non-Italians tested positive during the last time-
period (20 June–19 July), possibly explained by an increase in the
number of cases imported from abroad. In fact, a large part of the
imported cases notified to the surveillance system were tested posi-
tive in the last period (79%), most of them in non-Italian nationals
(77%). Although we excluded from our analysis, all cases imported
from abroad, part of them could have not been promptly detected
and quarantined at their arrival to Italy and might have favoured the
circulation of the virus within the foreign community.
Our results do not support previous findings around the hypo-
thetical protective effect of the BCG vaccination against severe in-
fection and death from SARS-CoV-2,21 as we found an increased
risk of hospitalization and admission to ICU in non-Italian cases,
including those from countries were BCG is part of the vaccination
schedule.
This is, to the best of our knowledge, the first analysis that com-
pares the epidemiology of the SARS-CoV-2 infection in the non-
national population using individual data. It is based on informa-
tion collected from the Italian integrated COVID-19 surveillance
system, which covers the entire national territory.
Figure 2 COVID-19 epidemiological curves in non-Italian nationals (A) and Italian nationals (B), week 8/2020 (17–23 February) to week 29/
2020 (13–19 July). HDI, human development index; Pct., percentile
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However, this analysis has also some limitations. Unfortunately,
we were not able to retrieve reliable estimates of the population size
at-risk of infection because the last available population estimates
were updated on 1 January 2020. Therefore, these estimates do not
account for possible population movement occurred in the foreign
population, especially during the early phase of the epidemic. This
did not consent to accurately estimate and compare the attack rate
of SARS-Cov-2 infection between non-Italian nationals and Italian
nationals.
Other limitations are mainly related to completeness of surveil-
lance data. We were not able to retrieve information about nation-
ality for 12% of all cases notified during the study period and this
could have introduced a bias in our estimates. We conducted a
sensitivity analysis assuming that cases with no information about
nationality but with a fiscal code indicative that they were born
abroad or in Italy were non-Italian nationals or Italian nationals,
respectively. Based on this assumption, we were able to classify 3189
cases as non-Italians and 24 793 cases as Italians out of the 28 942
cases excluded from the analysis. We found that the direction and
magnitude of the associations between nationality and all the ana-
lyzed outcomes were substantially the same as those presented in the
Results section, thus suggesting that this kind of bias was reduced to
a minimum (detailed results of sensitivity analysis are presented in
Supplementary table S6).
Finally, we were not able to obtain a reliable estimate of the date
of onset of symptoms for cases who were symptomatic at the time of
diagnosis because the information was missing for 21% of them. We
think, however, that using the difference between the self-reported
date of symptom onset and the date of diagnosis to assess possible
delay in diagnosis could have been misleading because this informa-
tion may be strongly affected by a desirability bias. As the social and
cultural factors that could influence people’s fear of being stigma-
tized and punished for reporting social interactions while symptom-
atic (e.g. for work purposes) may be different in nationals compared
with non-nationals, we felt that including this analysis would, there-
fore, also have been problematic.30
In conclusion, our results suggest that, compared to Italian cases,
non-Italian cases are more likely to experience a delayed access to
health services. Accessing care when the disease is more advanced
and clinical conditions possibly more severe can explain why it is
more likely for non-Italian nationals to require hospitalization and
admission to ICU. Compared to Italian cases, differences in clinical
Table 2 Case fatality, hospitalization rate, rate of admission to intensive care units and in-hospital case fatality in non-Italian nationals
compared to Italian nationals
Case fatality Cases Deaths (%) Crude RR (95% CI) Adj. RRa (95% CI)
Nationality (1)
Italian 194 956 27 836 14.3 ref. ref.
Non-Italian 15 504 390 2.5 0.18 (0.16–0.19) 1.01 (0.91–1.14)
Nationality (2)
Italian 194 956 27 836 14.3 ref. ref.
Low-HDI countries 3255 53 1.6 0.11 (0.09–0.15) 1.32 (1.01–1.75)
Medium-HDI countries 8246 237 2.9 0.20 (0.18–0.23) 1.03 (0.89–1.18)
High-HDI countries 4003 100 2.5 0.17 (0.14–021) 0.85 (0.69–1.04)
Hospitalization rate Cases Hospitalized (%) Crude RR (95% CI) Adj. RRa (95% CI)
Nationality (1)
Italian 195 225 75 432 38.6 ref. ref.
Non-Italian 15 507 4884 31.5 0.82 (0.79–0.84) 1.39 (1.33–1.44)
Nationality (2)
Italian 195 225 75 432 38.6 ref. ref.
Low-HDI countries 3255 925 28.4 0.74 (0.69–0.78) 1.59 (1.48–1.71)
Medium-HDI countries 8249 2970 36.0 0.93 (0.90–0.97) 1.46 (1.39–1.53)
High-HDI countries 4003 989 24.7 0.64 (0.60–0.68) 1.15 (1.07–1.23)
Rate of admission to ICU
in hospitalized cases
Hospitalized cases Admitted to ICU (%) Crude RR (95% CI) Adj. RRa (95% CI)
Nationality (1)
Italian 75 432 9066 12.0 ref. ref.
Non-Italian 4884 549 11.2 0.94 (0.86–1.02) 1.19 (1.07–1.32)
Nationality (2)
Italian 75 432 9066 12.0 ref. ref.
Low-HDI countries 925 92 9.9 0.83 (0.67–1.02) 1.16 (0.93–1.44)
Medium-HDI countries 2970 354 11.9 0.99 (0.89–1.10) 1.25 (1.11–1.42)
High-HDI countries 989 103 10.4 0.87 (0.71–1.05) 1.07 (0.88–1.32)
Case fatality in hospitalized cases Hospitalized cases Deaths (%) Crude RR (95% CI) Adj. RRa (95% CI)
Nationality (1)
Italian 75 252 20 823 27.7 ref. ref.
Non-Italian 4883 327 6.7 0.24 (0.22–0.27) 0.93 (0.83–1.04)
Nationality (2)
Italian 75 252 20 823 27.7 ref. ref.
Low-HDI countries 925 37 4.0 0.14 (0.10–0.20) 0.93 (0.67–1.29)
Medium-HDI countries 2969 206 6.9 0.25 (0.22–0.29) 0.93 (0.80–1.07)
High-HDI countries 989 84 8.5 0.31 (0.25–0.38) 0.94 (0.76–1.17)
RR, rate ratio; CI, confidence interval; ICU, intensive care unit; ref., reference category.
a: Adjusted for sex, age group, geographical macro-area of diagnosis, level of urbanization of the place of residence, pre-existing comor-
bidities and calendar period of diagnosis and accounting for the random effect due regional contextual differences.
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outcomes appear more pronounced in non-Italian cases from coun-
tries with lower HDI and reduced in those from high-HDI coun-
tries. Ensuring that all national disease prevention, diagnosis,
treatment and control measures are made more accessible to all
foreigners, also through enhanced and targeted communication
strategies, could facilitate earlier detection of new infections and
case management as well as the isolation of cases and the tracing,
quarantine and monitoring of their close contacts. Removing
healthcare access barriers and reinforcing communication are, there-
fore, essential to control SARS-CoV-2 transmission, preserve health
services and improve the health outcomes of all people living in the
same country, regardless of nationality.
Supplementary data
Supplementary data are available at EURPUB online.
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Key points
• Compared to Italian cases of COVID-19, non-Italian cases
were more likely to be hospitalized and admitted to an inten-
sive care unit (ICU), also showing an increased probability to
die in those from countries with a low human development
index (HDI).
• The risk of hospitalization, admission to ICU, and death
increased as the HDI of the country of origin decreased.
• Non-Italian cases were diagnosed 2 weeks later compared to
Italian cases, thus suggesting that a delayed diagnosis possibly
led to worse outcomes.
• If non-nationals are hindered in accessing healthcare services
in a timely manner, testing, tracking and tracing policies can
be delayed with a possible negative impact on individual out-
come and on disease prevention and control at population
level.
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The impact of COVID-19 restriction measures on
loneliness among older adults in Austria
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Background: To halt the spread of COVID-19, Austria implemented a 7-week ‘lockdown’ in March/April 2020. We
assess whether the ensuing reduction in social contacts led to increased loneliness among older adults (60þ).
Methods: Three analyses were conducted: (i) a comparison between pre-pandemic (SHARE: 2013–17) and pan-
demic (May 2020) levels of loneliness (UCLA-3 scale), (ii) an assessment of the cross-sectional correlation between
being affected by COVID-19 restriction measures and loneliness (May 2020) and (iii) a longitudinal analysis of
weekly changes (March–June 2020) in loneliness (Corona panel). Results: We found (i) increased loneliness in 2020
compared with previous years, (ii) a moderate positive association between the number of restriction measures
older adults were affected from and their loneliness and (iii) that loneliness was higher during ‘lockdown’
compared to the subsequent re-opening phase, particularly among those who live alone. Conclusions: We found
evidence that COVID-19 restriction measures in Austria have indeed resulted in increased levels of loneliness
among older adults. However, these effects seem to be short-lived, and thus no strong negative consequences
for older adults’ mental health are expected. Nonetheless, the effects on loneliness, and subsequent mental
health issues, could be both more long-lasting and severe if future restriction measures are enacted repeatedly
and/or over longer time periods.
. . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . .
Introduction
T
he pandemic Coronavirus disease 2019 (COVID-19) represents
an acute global health threat to human populations,1 with older
adults particularly at risk for complications and death.2
Overburdened health care systems, and high mortality rates in sev-
eral hot spots early in the pandemic (e.g. Lombardy in Italy) have
led to unprecedented governmental public health measures to miti-
gate the spread of SARS-CoV-2. Many European countries restricted
citizens’ movement and social contacts with stay-at-home orders,
quarantines and ‘shut-downs’ of public life over the course of several
weeks or months.3 In Austria, the so called first ‘lockdown’ began on
16 March 2020 with the closing of stores, bars and restaurants,
visiting bans in hospitals and nursing care homes, closing and/or
controlling of borders and regional quarantines. People were
informed to stay at home and were allowed to leave the house
only to go to work, buy groceries, help care-dependent others, or
to take a walk, all while keeping at least 1 m distance. In total, the
strict phase of these restrictions lasted for 7 weeks, between mid-
March and the end of April in Austria. Since COVID-19 cases
declined shortly after these measures were enacted and COVID-19
deaths remained limited, most restrictions were again relaxed
throughout May and early June 2020.
Although the enacted public health measures have limited the
spread of infection in Austria in the first half of 2020 while lasting
only several weeks, there could be negative psychosocial side-effects,
such as increased loneliness due to social isolation. Older adults are
not only more vulnerable to COVID-19, but also—already before
the pandemic—had an increased risk of loneliness due to widow-
hood, living alone or mobility limitations.4,5 Particularly older
adults who live alone might face an increased risk of loneliness,
when social contacts with persons from outside the household are
substantially reduced due to the pandemic.6,7 Loneliness can be
defined as a negative discrepancy between the desired and the
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